Back to chloroquine for malaria prophylaxis in pregnancy?

Chico, R Matthew and terKuile, Feiko ORCID: https://orcid.org/0000-0003-3663-5617 (2018) 'Back to chloroquine for malaria prophylaxis in pregnancy?'. Lancet Infectious Diseases, Vol 18, Issue 10, pp. 1051-1052.

Text Chico and ter Kuile-LancetID Commentary MiP-CQ-04Jul18.docx - Published Version Download (55kB)

Abstract

Malaria is among the most common preventable causes of adverse pregnancy outcomes. WHO recommends intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine for HIV-negative women; however, parasite resistance now threatens the effectiveness of this approach.

Item Type:	Article
Subjects:	QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 256 Antimalarials WC Communicable Diseases > Tropical and Parasitic Diseases > WC 750 Malaria WQ Obstetrics > Pregnancy > WQ 200 General works
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1016/S1473-3099(18)30427-4
Depositing User:	Stacy Murtagh
Date Deposited:	18 Sep 2018 08:52
Last Modified:	05 Mar 2019 02:02
URI:	https://archive.lstmed.ac.uk/id/eprint/9294

Statistics

View details

Actions (login required)

Edit Item